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A B S T R A C T
The influence of the DNA extraction method on the sensitivity and specificity of bacteraemia detection by a
16S rRNA gene PCR assay was investigated. The detection limit of the assay was 5 fg with purified DNA
from Escherichia coli or Staphylococcus aureus, corresponding to one bacterial cell. However, with spiked
blood samples, the detection limits were 104 and 106 CFU ⁄mL, respectively. The sensitivity of the S. aureus
assay was improved to the level of the E. coli test with the addition of proteinase K to the commercial DNA
extraction kit protocol. Ten (16.6%) of 60 amplification reactions were positive with templates isolated from
sterile blood, while PCR reagent controls were negative, thereby indicating contamination during the DNA
extraction process. Blood samples were spiked with serial dilutions of E. coli and S. aureus cells, and six PCR
results were obtained from three extractions for each blood sample. A classification threshold system was
devised, based on the number of positive reactions for each sample. Samples were deemed positive if at
least four positive reactions were recorded, making it possible to avoid false-positive results caused by
contamination. These results indicate that a comprehensive validation procedure covering all aspects of
the assay, including DNA extraction, can improve considerably the validity of PCR assays for bacteraemia,
and is a prerequisite for the meaningful detection of bacteraemia by PCR in the clinical setting.
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I N T R O D U C T I O N
Many intensive care patients present with clinical
signs of sepsis [1], but bacteraemia is rarely
detected by blood culture (BC) [2–4], which is
currently the standard diagnostic method [5]. One
possible explanation is that other, non-infectious
mechanisms, e.g., cytokine cascade activation [6],
are responsible for the symptoms mimicking the
clinical picture of sepsis. Another possible expla-
nation is that bacteria present in the blood are not
always detectable by BC as a result of insufficient
microbial growth in the culture medium [7,8]. As
there are uncertainties about the meaning of
negative BC results, and since there is still no
other tool for distinguishing infectious episodes
from other pathogenic mechanisms causing severe
systemic inflammation, early broad-spectrum
antibiotic treatment is commenced in most of these
unclear cases [9]. Reliable detection of bacteraemia
would provide more rational guidance for appro-
priate antibiotic use and patient management. In
this context, the use of PCR could have advan-
tages, since it detects the presence of bacteria
without requiring culture [10–13]. However, the
value of the molecular approach for clinical
diagnostic use is still unclear.
It has been suggested that universal primers may
be used to diagnose bacteraemia [11,14–18]. Such
primers are derived from gene sequences highly
conserved across all bacteria. The most common
target is the 16S rRNA gene, which is present in
multiple copies in all known eubacterial patho-
gens. PCR with universal 16S rRNA gene primers
was expected to detect bacteraemia more reliably
than BC. However, superior sensitivity with PCR
assays could only be demonstrated in the small
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group of patients who had received antibiotics
before diagnostic tests for bacteraemia [11]; more-
over, the reliability of such results was called into
question because the rate of false-positive findings
was as high as 40% [19].
Efforts to improve the reliability of universal
PCR assays have focused mainly on the develop-
ment of methods to eliminate DNA contamin-
ation originating from the PCR mastermix
reagents [20,21]. However, when blood is tested
for the presence of bacteria by universal PCR
assays, contamination of the samples can also
occur during DNA extraction as a result of cross-
transmission of DNA between samples or con-
tamination of the DNA extraction reagents. Thus,
the specificity and sensitivity of universal PCR for
bacteraemia samples might depend on the precise
DNA extraction procedure used. For instance, the
different cell-wall structures of Gram-positive and
Gram-negative bacteria can lead to different DNA
yields [14,22]. Neglecting to take this fact into
consideration can result in distorted data con-
cerning the spectrum of pathogens causing bac-
teraemia when universal PCR assays are used for
epidemiological investigations. However, system-
atic studies on the influence of DNA extraction
procedures for bacteraemia detection by PCR
with universal primers are scarce [14,23]. More-
over, a number of clinical studies comparing
PCR-based assays with BC have failed to provide
information on the quality of the extraction
method. Neither the detection limit for bacteria
in blood samples [14,15] nor the proportion of
false-positive results obtained from the blood of
healthy volunteers [14,17,19] have been reported.
Therefore, the objective of the present study was
to assess the influence of the DNA extraction
method on the sensitivity and specificity of the
detection of bacteria in human blood using a 16S
rRNA gene PCR. Based on comprehensive valid-
ation of the diagnostic assay, including the DNA
extraction procedure, an evaluation method
which made it possible to differentiate between
detection of actual bacteraemia and contaminated
blood specimens was established.
M A T E R I A L S A N D M E T H O D S
Primers
PCR was performed with primers L1, 5¢-CAGCAGCCGC-
GGTAATAC-3¢, and L2, 5¢-CCGTCAATTCCTTTGAGTTT-3¢,
corresponding to the 518–536-bp and 928–908-bp regions of the
Escherichia coli 16S rRNA gene, respectively [20]. The expected
length of the amplification product was 410 bp.
DNA amplification
PCR reactions were performed in a total volume of 50 lL with
5 lL of template DNA. Except for the primers, all the PCR
reagents of the mastermix were pretreated with 0.1 U of DNase I
for 30 min at 37 C, followed by heating at 95 C for 50 min [24].
The mastermix contained 10 mM Tris-HCl, 50 mM KCl, 3.5 mM
MgCl2, 200 lM of each dNTP (Amersham, Freiburg, Germany),
0.8 lM of each primer and 1.25 U of AmpliTaq Gold polymerase
(Applied Biotechnology, Weiterstadt, Germany). The PCR
program consisted of an initial denaturation step at 94 C for
10 min, followed by 50 cycles at 94 C for 20 s, 55 C for 20 s, and
72 C for 45 s, and a final elongation phase at 72 C for 5 min,
carried out in a Hybaid Omni Gene Temperature Cycler (MWG
Biotech, Ebersberg, Germany). PCR products were electro-
phoresed with 2 lL of gel loading buffer (bromophenol blue
0.25% w ⁄v and saccharose 40% w ⁄v) through an agarose 2%
w ⁄v gel at110 V for 45 min in Tris-acetate-EDTA buffer.Molecu-
lar size markers (Promega, Madison, WI, USA) were run concur-
rently. Gels were stained with ethidium bromide 0.5 mg ⁄L,
examined under UV light and photographed. The sensitivity
limit of the PCR was assessed using 5 lL of decreasing
concentrations (105)10fg ⁄ lL) of purified E. coli (Amersham)
and Staphylococcus aureus DNA (the kind gift of Dr C. Goerke).
PCR negative and positive controls, in which sample
templates were replaced with sterile water (Delta-Pharma,
Pfullingen, Germany), or 50 pg of E. coli or S. aureus DNA,
respectively, were run concurrently with samples. Amplifica-
tion runs were evaluated if the positive control yielded a band
of the expected length while the negative control did not.
Avoiding contamination during DNA extraction,
mastermix preparation and amplification
Precautions were taken to prevent DNA cross-contamination
[25,26]. DNA extractions, mastermix preparation, template
addition and agarose gel electrophoresis were carried out in
separate rooms under laminar flow hoods. Separate dedicated
pipetting devices with filter-sealed tips were used for each
procedure, and UV-light irradiation was used before each
procedure. Every stage of the PCR was performed by a
different operator. During DNA extraction and mastermix
preparation, the operators wore disposable protective clothing.
Bacterial strains and control experiments
Control strains, S. aureus ATCC 35556 and E. coli ATCC 11229,
were cultured overnight in CYPG broth [27] and tryptic soy
broth (Sigma, Deisenhofen, Germany), respectively. S. aureus
and E. coli cultures were centrifuged, washed three times in
physiological saline pH 7.4, and adjusted to a concentration of
108 CFU ⁄mL, verified by colony counting on blood agar after
incubation for 24 h at 37 C.
As a positive control for the extraction methods (see below),
serial dilutions of E. coli (103)106 CFU) or S. aureus
(104)107 CFU) were suspended in 100 lL of physiological
saline and added to 900 lL of whole blood from healthy
volunteers. Whole blood samples without added bacteria
served as negative blood controls.
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DNA extraction from blood samples
Basic extraction procedure
Samples (300 lL) were extracted with the Puregene whole
blood kit (Biozym Diagnostics, Hessisch Oldendorf, Germany),
supplemented with lytic enzyme (Puregene DNA extraction
kit for Gram-positive bacteria; Biozym). Briefly, erythrocytes
were lysed according to the manufacturer’s instructions by
incubating samples with 900 lL of red cell lysis buffer for
5 min at room temperature. Samples were centrifuged for 20 s
at 13 000 g. Cell pellets were resuspended in 100 lL of cell
suspension solution and 1 lL of lytic enzyme for 30 min at
37 C. After centrifugation at 15 000 g for 1 min at 4 C, 300 lL
of cell lysis solution were added, and samples were incubated
at 37 C for 90 min, followed by 80 C for 5 min. Protein
precipitation, DNA precipitation and DNA resuspension were
performed according to the manufacturer’s instructions.
Blood samples (1 mL) were spiked with 103, 104, 105 or
106 CFU of E. coli, or 104, 105, 106 or 107 CFU of S. aureus. Each
1-mL sample was divided into three aliquots of 300 lL for
DNA extraction, and PCR assays were performed in duplicate.
Therefore, each 1-mL sample yielded six PCR results, and each
series of spiked blood samples was performed five times.
To test whether PCR inhibitors were present in the
templates obtained from these whole blood samples, samples
of the E. coli DNA standard (5 · 106 fg, 5 · 104 fg, 5 · 102 fg,
5 · 10 fg) were amplified in the presence of: (1) 5 lL of
template extracted from sterile blood; and (2) 5 lL of sterile
water. Potential inhibition was assessed by comparing the
amplification products observed in the two series.
Improved DNA extraction procedure for Gram-positive bacteria
After incubation with the cell lysis solution, samples were put
on ice for 5 min before adding 15 lL of proteinase K (Biozym)
20 mg ⁄mL for overnight incubation at room temperature. This
procedure was tested as described above with E. coli and
S. aureus inocula of 104, 105 and 106 CFU ⁄mL whole blood. The
tests for each bacterial concentration were also performed five
times; in addition, ten sterile samples were tested.
A new evaluation procedure for universal PCR based on a
classification threshold
Each of the six PCR results obtained from a single 1-mL
sample was considered independently. The classification
threshold, i.e., the number of positive PCR results required
to define a sample as positive, was increased incrementally
(i.e., 1 ⁄ 6, 2 ⁄ 6, 3 ⁄ 6, etc.). An assessment of the number of false-
positive results for sterile blood samples was made at each
classification threshold, and the sensitivity of detection of the
spiked blood samples. This procedure assessed how many
false-positive diagnoses would result with each of the different
classification thresholds.
R E S U L T S
Influence of DNA extraction procedures
on PCR sensitivity and specificity
The sensitivity of the PCR was determined ini-
tially with purified bacterial DNA to be 5 fg in
49 (98%) of 50 reactions, equivalent to the DNA
content of one E. coli cell [28]. There was one (2%)
false-positive result with the reagent negative
controls.
When 103 CFU of E. coli were inoculated into
five independent 1-mL blood samples (yielding a
total of 30 PCR results), there were nine (30%)
positive results, while 20 (66%), 22 (73.3%) and 26
(86.6%) reactions were positive with 104, 105 and
106 CFU, respectively (Fig. 1a). When blood sam-
ples were spiked with 104)107 CFU of S. aureus,
the proportion of positive PCR results rose from
3.3% to 70% (Fig. 1b).
To test whether positive PCR results were true
positives, i.e., reflected the actual presence of
bacteria in blood, ten unspiked 1-mL blood
samples of healthy volunteers were extracted
and amplified. Ten (16.6.%) of 60 amplifications
gave false-positive results. Therefore, E. coli or
S. aureus had to be present in blood samples in
concentrations ‡ 104 CFU ⁄mL and 106 CFU ⁄mL,
respectively, to obtain more positive PCR results
than the blood negative control (Fig. 1a). Hence,
the detection limits for E. coli and S. aureus were
104 CFU ⁄mL and 106 CFU ⁄mL, respectively.
Fig. 1. Proportion of single positive PCR results after
inoculation of sterile blood with S. aureus (white bars) or
E. coli (black bars) with the basic (a) and improved (b)
extraction procedure.
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A series of decreasing dilutions of pure E. coli
DNA was amplified in the presence of sterile
blood sample templates. The amplification of
E. coli DNA was not impaired (Fig. 2), indicating
that PCR sensitivity was not affected by blood
sample inhibitors.
The addition of proteinase K to the extraction
process improved the sensitivity of the S. aureus
assay for samples containing 104 CFU, from 3.3%
positive reactions (Fig. 1a) to 36.6% positive
reactions (Fig. 1b). Similar effects were noted
with higher bacterial inocula. No such improve-
ment was observed when proteinase K was added
to E. coli extractions (Fig. 1b).
A new evaluation procedure for universal PCR
based on a classification threshold
Initially, the PCR results from ten sterile blood
samples, extracted with the basic procedure, were
used to test the impact of different classification
thresholds on the specificity of PCR-based bac-
teraemia detection. By increasing the classification
threshold incrementally, from one to four positive
results out of six, the frequency of false-positive
results was reduced from 50% to zero (Fig. 3).
These different classification thresholds were
also applied to the evaluation of amplifications
from blood samples spiked with known concen-
trations of E. coli or S. aureus (Table 1). If one
positive amplification result was used as the
classification threshold, bacteraemia would have
been diagnosed in three (60%) of the five samples
containing 103 CFU E. coli. With a classification
threshold of four, shown to eliminate false-posit-
ive findings in sterile samples, the rate of positive
findings decreased to one (20%) of five tested
samples. When the tested samples were evaluated
with higher inocula, the decrease in the number of
positive findings was marginal or even zero when
the classification threshold was raised from one to
four (Table 1).
D I S C U S S I O N
In the first clinical studies, PCR results were
compared with conventional BC results to dem-
onstrate the usefulness of the molecular approach
for the diagnosis of bacteraemia. Positive PCR
results, despite sterile BCs, were interpreted as a
sign of the superior sensitivity of PCR
[11,14,15,17,19]. However, since a third independ-
ent method of diagnosing bacteraemia does not
exist, it is not possible to tell with absolute
certainty whether positive PCR results in the
presence of negative BCs are true- or false-
positives. Similarly, should a negative PCR in
the presence of a positive BC be interpreted as a
false-negative PCR result or as a false-positive BC
result? This could be resolved by ensuring a
correct amplification process, with negative re-
sults for reagent controls and positive results for a
standard dilution of pure bacterial DNA. How-
ever, since the influence of the template prepar-
ation process on the sensitivity and the specificity
of PCR-based diagnostic examinations is un-
known, the problem remains unresolved [19,29].
Fig. 2. Amplification of serial dilutions of E. coli DNA in
the presence and absence of DNA extracted from sterile
blood samples. Lane 0: reagent negative control. Lanes 1–4:
E. coli DNA (5 · 106 fg, 5 · 104 fg, 5 · 102 fg, and
5 · 10 fg) plus 5 lL of blood sample extract. Lanes 5–8:
E. coli DNA (5 · 106 fg, 5 · 104 fg, 5 · 102 fg, and
5 · 10 fg) plus 5 lL of sterile water. M, DNA size marker.
Fig. 3. Results of six amplification reactions for ten sterile
blood samples and varying classification thresholds for the
diagnosis of bacteraemia.
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Universal PCR is highly sensitive, and even
minor contamination with DNA of any bacterial
species may result in false-positive findings.
Mastermix reagents are frequently a source of
contamination [30,31], and decontamination
measures are generally necessary [21,32–34]. The
present study demonstrated that the reliability of
PCR for the diagnosis of bacteraemia was also
influenced heavily by the DNA extraction proce-
dure used. When DNA was isolated from
blood samples of healthy volunteers with a
commercially available kit, there were 16.6%
false-positive results. This high rate could not be
attributed to the amplification procedure, because
only PCR results with negative reagent controls
were evaluated. Thus, contamination must have
occurred before amplification. This is consistent
with another study [35] in which considerable
amounts of bacterial DNA were detected in the
blood of healthy subjects in the presence of
negative reagent controls. Nikkari et al. [35]
explained these findings by postulating that small
amounts of bacterial DNA might be normal in
the blood of healthy subjects, or that bacteria can
be transmitted from the skin into the blood
specimens, despite meticulous hygienic precau-
tions during venipuncture.
Contamination might also originate from the
extraction reagents; for example, the lytic enzyme
solution used as part of the DNA extraction kit in
the present study might contain bacterial DNA.
This conjecture is based on the fact that this
enzyme originates from Arthrobacter luteus (Gen-
tra Systems, personal communication). As already
shown for Taq polymerases from various suppli-
ers, the purification procedures applied for the
preparation of enzymes from bacteria cannot
eliminate traces of bacterial DNA completely
[20,30,31]. Furthermore, it has been demonstrated
that Taq polymerases, if used without additional
decontamination steps, frequently cause false-
positive amplification results when universal
primers are applied [21,33].
The false-positive amplification results
occurred sporadically and were distributed ran-
domly. Therefore, a new evaluation method was
developed to distinguish between true- and false-
positive PCR results, for which multiple extrac-
tions and amplification reactions for each sample
were necessary. The hypothesis that repeat PCR
testing improves the reliability of molecular
detection of bacteraemia is supported by the data
of Ley et al. [11], where bacteraemia diagnosis
was based on two PCR-positive results and the
rate of false-positive PCR results from the blood
of healthy volunteers was < 5%. In contrast,
Sleigh et al. [19] did not monitor PCR reliability
in vitro and reported 40% false-positive results
with clinical samples.
To be of value for clinical decision-making,
PCR examinations for bacteraemia must be
not only specific, but also highly sensitive [17].
The findings in the present study identified the
extraction method as a limiting factor for
the sensitivity of a PCR-based assay. Although
the detection limit of the present assay with
purified E. coli DNA was similar to that reported
by Ley et al. [11] and Golbang et al. [23], this was
reduced by a factor of 103 for E. coli and a factor
of 105 for S. aureus with complete bacteria. This
difference was not caused by insufficient
removal of the PCR inhibitors present in the
blood [36], since adding an extract from sterile
blood did not affect the amplification of serial
dilutions of a DNA standard. Thus, considerable
loss of template DNA during the extraction
procedure appears to be the most probable
explanation. Moreover, the use of proteinase K
for DNA extraction indicates that an additional
mechanism might limit the availability of Gram-
positive template DNA. The supplier’s statement
that augmented lysis of clumping cells is the
Table 1. A new evaluation proce-
dure applied to universal PCR
results obtained from blood samples




Percentage of the examination results classified as positive bacteraemia
Concentrations of E. coli/S. aureus in 1-mL blood samples (CFU)
103/mL 104/mL 105/mL 106/mL 107/mL
1 ⁄ 6 60 ⁄nt 80 ⁄ 20 80 ⁄ 40 100 ⁄ 80 nt ⁄ 100
2 ⁄ 6 60 ⁄nt 80 ⁄ 0 80 ⁄ 0 100 ⁄ 60 nt ⁄ 100
3 ⁄ 6 40 ⁄nt 80 ⁄ 0 80 ⁄ 0 100 ⁄ 60 nt ⁄ 80
4 ⁄ 6 20 ⁄nt 60 ⁄ 0 80 ⁄ 0 100 ⁄ 60 nt ⁄ 60
5 ⁄ 6 0 ⁄nt 60 ⁄ 0 60 ⁄ 0 80 ⁄ 40 nt ⁄ 60
6 ⁄ 6 0 ⁄nt 40 ⁄ 0 60 ⁄ 0 40 ⁄ 20 nt ⁄ 20
aNumber of PCR-positive results necessary to define a sample as positive (Fig. 3).
nt, not tested.
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main effect of proteinase K seems unlikely in this
context, since this should hold true for both
bacterial species tested. Two potential explana-
tions for the effects of proteinase K might occur
specifically in Gram-positive bacteria: (1)
improvement in cell-wall disruption [37]; and
(2) DNase activity, which is found typically in
S. aureus [38], but not in E. coli. Nakajima et al.
[39] demonstrated that DNase activity of a target
microorganism can lead to DNA degradation,
and that proteinase K can prevent such degra-
dation.
In conclusion, the present study demonstrated
that the DNA isolation procedure used to prepare
templates from blood samples influences the
sensitivity and the specificity of PCR-based assays
for the detection of bacteraemia substantially.
Any meaningful interpretation of studies of uni-
versal PCR for the diagnosis of bacteraemia
requires validity testing of the DNA extraction
method for clinical samples.
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